Arvinas Holding Company (ARVN) Stock Research

Today

Arvinas price target lowered by $1 at Morgan Stanley

ARVN

8:21 AM

Arvinas price target lowered by $5 at Evercore ISI

ARVN

8:14 AM

Arvinas price target lowered by $3 at Citi

ARVN

6:49 AM

Wednesday

Arvinas price target raised by $1 at Wedbush, here's why

ARVN

Aug 5, 7:55 AM

Tuesday

Wells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027

ARVN

Aug 4, 1:16 PM

Wells Fargo gets more bearish on Arvinas, downgrades shares

ARVN

Aug 4, 1:10 PM

Arvinas reports Q2 EPS $2.58, consensus (28c)

ARVN

Aug 4, 8:00 AM

Over a week ago

Rigel closes license agreement for Veppanu

Jun 16, 4:05 PM

Citizens biotech analysts hold a dinnermeeting at ASCO

May 22, 3:19 PM

Arvinas price target raised by $2 at BofA, here's why

May 13, 3:07 PM

Arvinas price target raised by $2 at BTIG, here's why

May 13, 7:15 AM

Arvinas price target raised by $2 at Barclays, here's why

ARVN

May 13, 4:57 AM

H.C. Wainwright says Pfizer handing off Veppanu to Rigel 'makes strategic sense'

May 12, 12:12 PM

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

May 12, 7:55 AM

Arvinas reports Q1 EPS (90c), consensus (63c)

ARVN

May 12, 7:36 AM

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

May 12, 7:10 AM

Arvinas management to meet with BTIG

ARVN

May 4, 3:27 PM

Guardant Health receives FDA approval for Guardant360 CDx

May 4, 8:09 AM

Arvinas price target raised by $3 at Citi, here's why

ARVN

May 4, 5:09 AM

Arvinas gets early approval for Vepdeg, says Truist

ARVN

May 1, 1:13 PM

Arvinas trading resumes

ARVN

May 1, 1:05 PM

Arvinas announces FDA approval of VEPPANU for ESR1m, ER+/HER2- ABC

May 1, 12:45 PM